Clinical Trials
- Pancreatic Cancer, Prevention
The Cancer of the Pancreas Screening-5 (CAPS5) Study
- Ages18 years and older
- GenderBoth
- Date05/12/2015
- Pancreatic Cancer
Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma
- Date06/06/2022
- Pancreatic Cancer
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs
- Date03/17/2021
- Pancreatic Cancer, Stomach and Esophagus
A Phase III Multi-center, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET
- Date06/08/2022
- Digestive System
SpHincterotomy for Acute Recurrent Pancreatitis Trial (SHARP Trial)
- Ages18 years and older
- GenderBoth
- Date02/18/2020
- Pancreatic Cancer
A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
- Date04/01/2022
- Lung Cancer
BAY1895344 Plus Topoisomerase-1 (Top1) Inhibitors in Patients With Advanced Solid Tumors, Phase I Studies With Expansion Cohorts in Small Cell Lung Carcinoma (SCLC), Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) and Pancreatic Adenocarcinoma (PDA)
- GenderBoth
- Date06/14/2022
- Phase 1 Cancers
A Phase 1/2 Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CM24 in Combination With Nivolumab in Adults With Advanced Solid Tumors
- Date06/14/2022